1 gen 2015 anni - (Varma et al., 2015)
Descrizione:
The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibition in 2006 hugely reduced legal blindness rates and achieved considerable improvements in vision in neovascular AMD and diabetic macular edema (DME)
Aggiunto al nastro di tempo:
Data:
~ 9 years and 5 months ago